N-(1-thiazolyl)-amide derivatives for the treatment of obesity, diabetes and cardiovascular diseases

摘要

The invention relates to the use of a compound of formula (I) :
its pharmaceutically acceptable salts, prodrugs and/or solvates, in the preparation of a medicinal product for the treatment of a disease presenting altered adiponectin levels or in which it is necessary to alter the adiponectin protein levels.